Balance Sheet of Concord Drugs Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Equity Share Capital	10.00	10.00	9.32	8.74	8.74
Share Application Money	0.00	0.00	0.00	0.00	0.00
Preference Share Capital	0.00	0.00	0.00	0.00	0.00
Reserves & Surplus	24.11	23.82	22.39	19.62	18.02
Secured Loans	14.86	14.01	14.80	16.43	12.97
Unsecured Loans	0.00	0.00	0.00	0.00	0.00
Gross Block	39.89	37.92	37.61	37.12	35.22
Depreciation	27.71	26.29	24.75	23.15	21.39
Net Block	12.17	11.63	12.86	13.97	13.83
Capital Work-in-progress	2.00	1.63	0.92	0.55	0.00
Investments	1.61	1.61	1.42	0.00	0.00
Current Assets, Loans & Advances	42.80	41.43	41.44	41.92	36.05
Total Net Current Assets	33.19	32.95	31.31	30.27	25.91
Miscellaneous expenses not written	0.00	0.00	0.00	0.00	0.00
Book Value of Unquoted Investments	0.00	0.00	0.00	0.00	0.00
Market Value of Quoted Investments	0.00	0.00	0.00	0.00	0.00
Contingent liabilities	0.00	0.00	0.00	0.00	0.00
Number of Equity shares outstanding (in Lacs)	1.00	1.00	0.93	0.87	0.87

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article